Xiaoli Wei
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 12
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 4
-
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Weiwei Gao (3 shared papers)Ronnie H. Fang (3 shared papers)Diana Dehaini (3 shared papers)Ying Man (3 shared papers)Liangfang Zhang (3 shared papers)Ashley V. Kroll (2 shared papers)Sarah Masson (2 shared papers)Brian T. Luk (2 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Journal of Cancer (3 papers)Advanced Materials (2 papers)Cancer Research (2 papers)Therapeutic Advances in Medical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaoli Wei
61 papers receiving 2.2k citations
Xiaoli Wei's Hit Papers
Peers
Comparison fields: 5 of 116
- Biomaterials 343
- Oncology 540
- Immunology 427
- Otorhinolaryngology 60
- Cancer Research 188
Countries citing papers authored by Xiaoli Wei
This map shows the geographic impact of Xiaoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Wei more than expected).
Fields of papers citing papers by Xiaoli Wei
This network shows the impact of papers produced by Xiaoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Wei. The network helps show where Xiaoli Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization Hit paper breakdown → | 2017 | 670 |
| 2 | 2010 | 184 | |
| 3 | 2015 | 141 | |
| 4 | 2018 | 82 | |
| 5 | 2020 | 71 | |
| 6 | 2014 | 57 | |
| 7 | 2014 | 56 | |
| 8 | 2022 | 54 | |
| 9 | 2022 | 51 | |
| 10 | 2016 | 49 | |
| 11 | 2022 | 49 | |
| 12 | 2022 | 41 | |
| 13 | 2017 | 38 | |
| 14 | 2022 | 37 | |
| 15 | 2020 | 33 | |
| 16 | 2019 | 29 | |
| 17 | 2021 | 29 | |
| 18 | 2022 | 28 | |
| 19 | 2023 | 27 | |
| 20 | 2020 | 26 |
About Xiaoli Wei
Xiaoli Wei is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 61 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), HER2/EGFR in Cancer Research (6 papers), Gastric Cancer Management and Outcomes (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune cells in cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cell Adhesion Molecules Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Biomaterials (343 citations), Oncology (540 citations), Immunology (427 citations), Otorhinolaryngology (60 citations) and Cancer Research (188 citations). Xiaoli Wei has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Weiwei Gao, Ronnie H. Fang, Diana Dehaini, Ying Man, Liangfang Zhang, Ashley V. Kroll, Sarah Masson, Brian T. Luk, Pavimol Angsantikul and Yue Zhang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer, Advanced Materials, Cancer Research and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.